ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 66 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $92,000 | -73.8% | 22,226 | -83.8% | 0.00% | – |
| Q2 2020 | $351,000 | +344.3% | 137,292 | +556.3% | 0.00% | – |
| Q4 2019 | $79,000 | -60.3% | 20,918 | -46.3% | 0.00% | – |
| Q3 2019 | $199,000 | -45.5% | 38,944 | -8.8% | 0.00% | -100.0% |
| Q4 2018 | $365,000 | +12.7% | 42,714 | +163.9% | 0.00% | 0.0% |
| Q3 2018 | $324,000 | +24.1% | 16,187 | +31.2% | 0.00% | 0.0% |
| Q3 2017 | $261,000 | +10.1% | 12,339 | -8.9% | 0.00% | 0.0% |
| Q2 2017 | $237,000 | +34.7% | 13,549 | +11.2% | 0.00% | 0.0% |
| Q1 2016 | $176,000 | -67.7% | 12,186 | -59.1% | 0.00% | -85.7% |
| Q2 2014 | $545,000 | – | 29,826 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 808,431 | $3,501,000 | 2.68% |
| AIGH Capital Management LLC | 875,851 | $3,793,000 | 1.54% |
| Healthcare Value Capital, LLC | 100,000 | $433,000 | 1.46% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 440,955 | $1,909,000 | 1.11% |
| Opaleye Management Inc. | 1,487,800 | $6,442,000 | 0.84% |
| Worth Venture Partners, LLC | 225,106 | $975,000 | 0.77% |
| ARMISTICE CAPITAL, LLC | 2,742,000 | $11,873,000 | 0.40% |
| DELTEC ASSET MANAGEMENT LLC | 245,399 | $1,063,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 278,011 | $1,204,000 | 0.15% |
| Mosaic Family Wealth, LLC | 91,807 | $398,000 | 0.13% |